Premarket Decliner
PLYX Polaryx Therapeutics5.93-2.98-33.5%
Premarket:5.09-0.84 (-14.2%)
Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium
Globe NewswireTue, 10-Feb 8:30 AM
